Marijuana PTSD Study in the Works in Arizona
MAPS is currently working with Principal Investigator Sue Sisley M.D., of Phoenix, Arizona to develop a new marijuana/PTSD protocol in order to get a marijuana study underway in the U.S. Weve already developed a protocol summary. Were anticipating that the protocol will be ready for submission to the Institutional Review Board (IRB) and the FDA this summer. Were sadly anticipating that this study is likely to be delayed for at least a year by NIDAs review process-- should they even approve it, which is doubtful. In addition, were asking for marijuana with THC and CBD in it, which NIDA does not have available.
There is not at yet a possibility of importing any marijuana into the United States that contains significant amounts of both THC and CBD. This shows clearly how the DEA support of NIDAs monopoly on the supply of marijuana for research is fundamentally obstructing drug development research aimed at transforming marijuana into an FDA-approved prescription medicine. The DEA/NIDA obstruction of FDA research is one of the primary reasons why state medical marijuana reform efforts are essential.